{"gene":"CCNT2","run_date":"2026-04-28T17:28:52","timeline":{"discoveries":[{"year":1998,"finding":"Human P-TEFb contains multiple cyclin subunits including Cyclin T1, Cyclin T2a, and Cyclin T2b (the latter two arising from alternative splicing of CCNT2). Cyclin T1 and T2 associate with CDK9 in a mutually exclusive manner, and almost all CDK9 is associated with either cyclin T1 or T2. Recombinant CDK9/CycT2a and CDK9/CycT2b complexes produced in Sf9 cells possess DRB-sensitive kinase activity and function in transcription elongation in vitro; truncation of the cyclin C-terminus reduces but does not eliminate P-TEFb activity.","method":"Immunoprecipitation, immunodepletion from HeLa nuclear extract, recombinant protein production in Sf9 cells, in vitro kinase assays, in vitro transcription elongation assays, cotransfection","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1 — reconstituted in vitro with functional assays, multiple orthogonal methods","pmids":["9499409"],"is_preprint":false},{"year":2001,"finding":"In human HeLa cells, more than half of P-TEFb (containing CDK9 and Cyclin T1 or T2) is sequestered in larger complexes also containing 7SK snRNA. The 7SK/P-TEFb complex shows very weak kinase activity compared to the smaller active P-TEFb complexes. Inhibition of transcription by chemical agents or UV irradiation triggers disruption of the P-TEFb/7SK complex and enhances CDK9 activity, indicating a feedback loop modulating RNA Pol II activity.","method":"Immunoprecipitation, sucrose gradient sedimentation, in vitro kinase assays, chemical inhibitor and UV treatment","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal methods, foundational paper replicated by subsequent work","pmids":["11713533"],"is_preprint":false},{"year":2003,"finding":"MAQ1 (HEXIM1) is a novel component of the inactive P-TEFb complex containing CDK9, Cyclin T1 or T2, and 7SK snRNA. MAQ1 binds directly to the N-terminal cyclin homology region of both Cyclin T1 and Cyclin T2 (by yeast two-hybrid and immunoprecipitation), and 7SK RNA is required for MAQ1 to associate with P-TEFb. The MAQ1/7SK complex competes with HIV Tat binding to Cyclin T1.","method":"Yeast two-hybrid, co-immunoprecipitation from transfected cell extracts, immunoprecipitation of endogenous complexes","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP plus yeast two-hybrid, replicated across labs","pmids":["12832472"],"is_preprint":false},{"year":2004,"finding":"HEXIM1 (MAQ1) binding to 7SK snRNA is required to convert HEXIM1 into a P-TEFb (CDK9/Cyclin T) inhibitor. In vitro reconstitution demonstrated 7SK-dependent HEXIM1 association to purified P-TEFb and subsequent CDK9 inhibition. A 7SK RNA-recognition motif was identified in the central part of HEXIM1 (aa 152–155) and direct P-TEFb binding to HEXIM1 C-terminal domain (aa 181–359) was mapped; mutations in a conserved motif (aa 202–205) suppress P-TEFb binding without affecting 7SK recognition.","method":"In vitro reconstitution of purified components, yeast three-hybrid, gel-shift assays, GST pull-down, point mutagenesis","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with purified components plus mutagenesis","pmids":["15201869"],"is_preprint":false},{"year":2001,"finding":"CDK9 and Cyclin T1 (and by extension P-TEFb complexes) localize throughout the non-nucleolar nucleoplasm and concentrate at nuclear speckles enriched in splicing factors. A central region of Cyclin T1 is important for speckle accumulation, and Cyclin T1 can recruit CDK9 and HIV Tat to this compartment. Treatment with transcription inhibitors alters the distribution of CDK9 and Cyclin T1, linking their localization to active transcription.","method":"High-resolution immunofluorescence microscopy, co-localization with splicing factor markers, transient expression of deletion mutants","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 — direct localization with functional mutants; primarily Cyclin T1, CycT2 localization inferred by complex membership","pmids":["11282025"],"is_preprint":false},{"year":2005,"finding":"Brd4 interacts with the active (HEXIM1/7SK-free) form of P-TEFb, which contains Cyclin T1 and CDK9, and stimulates P-TEFb-dependent phosphorylation of the RNA Pol II CTD and transcription. Reducing Brd4 by siRNA decreases CTD phosphorylation; ChIP shows Brd4-dependent recruitment of P-TEFb to promoters enhanced by increased chromatin acetylation.","method":"Proteomic analysis, co-immunoprecipitation, siRNA knockdown, ChIP, in vivo transcription assays","journal":"Molecular cell","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods; focus is on CycT1-containing P-TEFb; CCNT2 involvement inferred via complex","pmids":["16109376"],"is_preprint":false},{"year":2008,"finding":"Crystal structure of free Cyclin T2 was determined, revealing structural features of C-type cyclins. CDK9/CycT1 structure shows a 26° rotation of CycT1 relative to CDK9 compared with CDK2/CycA, demonstrating plasticity in CDK-cyclin interfaces. CDK9 autophosphorylates on Thr186 in the activation segment and three C-terminal sites; autophosphorylation on all sites occurs in cis and governs CDK9 activity and recognition of regulatory proteins.","method":"X-ray crystallography, in vitro kinase assay, mutagenesis","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 — crystal structure of free CycT2 plus CDK9/CycT1 structure with functional validation","pmids":["18566585"],"is_preprint":false},{"year":2009,"finding":"Genetic inactivation of the Ccnt2 gene (using beta-geo gene trap) in mice is embryonic lethal; no CycT2−/− embryos are recovered despite numerous heterozygous matings. CycT2 is expressed abundantly throughout embryogenesis and in all adult tissues. siRNA knockdown of CycT2 in embryonic stem cells identifies critical target genes, demonstrating that CycT1 and CycT2 regulate distinct subsets of genes and are not functionally redundant.","method":"Gene trap mutagenesis in mice, beta-galactosidase reporter expression analysis, siRNA knockdown in embryonic stem cells, gene expression analysis","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — clean genetic KO with defined lethal phenotype, replicated over multiple crosses, combined with cellular knockdown","pmids":["19364821"],"is_preprint":false},{"year":2011,"finding":"MED26, a Mediator subunit, contains overlapping docking sites in its conserved N-terminal domain for super-elongation complexes (SECs) containing ELL/EAF family members and P-TEFb (which includes Cyclin T subunits), as well as TFIID. MED26 can act as a molecular switch, first interacting with TFIID during initiation then exchanging for SEC/P-TEFb complexes to facilitate Pol II transition into elongation.","method":"Co-immunoprecipitation, affinity purification-mass spectrometry, ChIP, functional transcription assays","journal":"Cell","confidence":"Medium","confidence_rationale":"Tier 2 — multiple methods, but CCNT2 involvement is inferred through P-TEFb complex membership","pmids":["21729782"],"is_preprint":false},{"year":2014,"finding":"An RNAi screen identified CCNT2 (component of P-TEFb) as a functional ally of Aire in thymic epithelial cells for ectopic transcription of autoantigen genes. HNRNPL interacts directly with P-TEFb components CDK9, CCNT2, HEXIM1, and 7SK RNA, and Aire-containing complexes include 7SK RNA. HNRNPL knockdown disrupts 7SK RNA interaction with Aire-containing complexes, suggesting HNRNPL participates in delivering inactive P-TEFb to Aire to release stalled polymerases.","method":"Genome-scale lentiviral shRNA screen, RNA co-immunoprecipitation, lentigenic knockdown mice, flavopiridol inhibitor treatment, qRT-PCR","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2–3 — RNAi screen validated with multiple orthogonal methods including Co-IP and in vivo knockdown mice","pmids":["24434558"],"is_preprint":false},{"year":2016,"finding":"CCNT2 (the regulatory subunit of P-TEFb) is a direct functional target of miR-297c-5p in oligodendrocyte precursor cells (OPCs). Luciferase reporter assays confirmed miR-297c-5p targets CCNT2; CCNT2-specific knockdown promoted rOPC differentiation (increased O1+ cells) without affecting cell cycle status, while miR-297c-5p overexpression caused both G1/G0 arrest and enhanced differentiation. This places CCNT2 as an inhibitor of oligodendrocyte maturation.","method":"Luciferase reporter assay, lentiviral transduction, flow cytometry, immunostaining, siRNA knockdown","journal":"The Journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2–3 — luciferase validation plus functional knockdown with specific differentiation phenotype","pmids":["26843650"],"is_preprint":false},{"year":2016,"finding":"Silencing of CCNT2 in human adipocytes decreased leptin secretion and reduced mRNA expression of adipogenesis-related genes including MGLL, LIPE, PPARG, LEP, and ADIPOQ, establishing CCNT2 as a transcriptional regulator required for normal adipogenic gene expression.","method":"siRNA knockdown in human adipocytes, ELISA (leptin secretion), qRT-PCR","journal":"Diabetologia","confidence":"Medium","confidence_rationale":"Tier 3 — single-lab siRNA knockdown with defined gene expression phenotype","pmids":["27627980"],"is_preprint":false},{"year":2017,"finding":"miR-192 directly targets the 3'-UTR of CCNT2 (confirmed by dual-luciferase reporter assay with wild-type vs. mutated 3'-UTR), downregulates CCNT2 protein, and overexpression of CCNT2 attenuates miR-192-induced G0/G1 cell cycle arrest in NB4 and HL-60 AML cells, establishing CCNT2 as a functional driver of cell cycle progression in leukemia cells.","method":"Dual-luciferase reporter assay, qRT-PCR, Western blot, flow cytometry, rescue experiments with CCNT2 overexpression","journal":"International journal of hematology","confidence":"Medium","confidence_rationale":"Tier 3 — luciferase validation plus rescue experiment with specific cell cycle phenotype","pmids":["28409330"],"is_preprint":false},{"year":2021,"finding":"CCNT2 binds to both the promoter and the +157 distal enhancer of VEGFA (shown by ChIP), and CCNT2 silencing promotes exclusion of VEGFA exons 6a and 7 by slowing RNA Pol II elongation rate, demonstrating that CCNT2 regulates alternative splicing of VEGFA through its role in controlling transcription elongation speed.","method":"ChIP, siRNA silencing, RNA-seq/RT-PCR splice isoform analysis, RNAPII elongation rate measurement","journal":"NAR cancer","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP plus functional silencing with defined splicing phenotype, mechanistically linked to elongation rate","pmids":["34316716"],"is_preprint":false},{"year":2021,"finding":"NRF2 transcriptionally activates miR-29a-3p (confirmed by ChIP), which in turn directly targets and suppresses CCNT2 (validated by dual-luciferase reporter assay). In rat myocardial ischemia/reperfusion injury models, CCNT2 is upregulated while NRF2 and miR-29a-3p are downregulated; restoration of NRF2 or miR-29a-3p reduces CCNT2 levels, improving hemodynamics and reducing cardiomyocyte apoptosis via the NRF2/miR-29a-3p/CCNT2 axis.","method":"ChIP (NRF2 binding to miR-29a-3p promoter), dual-luciferase reporter assay, rat MI/RI model, H/R cell model, plasmid overexpression, flow cytometry, Western blot","journal":"BioFactors","confidence":"Medium","confidence_rationale":"Tier 2–3 — multiple orthogonal methods including ChIP and in vivo model with functional readouts","pmids":["33600051"],"is_preprint":false}],"current_model":"CCNT2 encodes Cyclin T2, the regulatory subunit of the positive transcription elongation factor b (P-TEFb) complex (together with CDK9), which phosphorylates the RNA Pol II CTD to promote transcriptional elongation; CCNT2-containing P-TEFb is held in an inactive state by 7SK snRNA/HEXIM1, is recruited to promoters and enhancers to control elongation rate and alternative splicing, is essential for mouse embryogenesis (with non-redundant functions relative to Cyclin T1), and regulates cell cycle progression and differentiation in multiple cell types including oligodendrocyte precursors, leukemia cells, and adipocytes."},"narrative":{"teleology":[{"year":1998,"claim":"Identification of Cyclin T2a and T2b as alternative splice-derived regulatory subunits of P-TEFb established that CDK9 partners with multiple cyclins to drive transcription elongation, resolving the molecular composition of the complex.","evidence":"Immunoprecipitation, recombinant protein reconstitution in Sf9 cells, in vitro kinase and transcription elongation assays in HeLa nuclear extracts","pmids":["9499409"],"confidence":"High","gaps":["Whether CycT2a and CycT2b have distinct substrate specificities or gene targets was not addressed","In vivo functional distinction between CycT1- and CycT2-containing P-TEFb remained unknown"]},{"year":2001,"claim":"Discovery that 7SK snRNA sequesters >50% of P-TEFb (including CycT2-containing forms) into inactive high-molecular-weight complexes revealed a major regulatory layer controlling elongation capacity, with stress-induced release as a feedback mechanism.","evidence":"Sucrose gradient sedimentation, co-immunoprecipitation, in vitro kinase assays with chemical inhibitor and UV treatment in HeLa cells","pmids":["11713533"],"confidence":"High","gaps":["The protein factor(s) mediating P-TEFb inhibition within the 7SK complex had not yet been identified","The stoichiometry of CycT2-containing vs CycT1-containing inactive complexes was not determined"]},{"year":2003,"claim":"Identification of HEXIM1 as the direct inhibitory protein within the 7SK/P-TEFb complex, binding the cyclin homology region of both CycT1 and CycT2, resolved how 7SK-dependent inhibition is executed at the molecular level.","evidence":"Yeast two-hybrid, co-immunoprecipitation of endogenous and transfected complexes","pmids":["12832472"],"confidence":"High","gaps":["The structural basis of HEXIM1–Cyclin T interaction was not resolved","Whether HEXIM1 preferentially inhibits CycT1- vs CycT2-containing P-TEFb was not tested"]},{"year":2004,"claim":"In vitro reconstitution demonstrated that 7SK RNA is required to convert HEXIM1 into an active P-TEFb inhibitor, mapping the RNA-recognition and P-TEFb-binding domains of HEXIM1, thereby defining the molecular logic of the inhibitory switch.","evidence":"Reconstitution with purified components, gel-shift assays, GST pull-down, point mutagenesis","pmids":["15201869"],"confidence":"High","gaps":["Whether CycT2-specific sequences differentially modulate HEXIM1 affinity was not examined","Signals that trigger 7SK release in vivo remained incompletely defined"]},{"year":2005,"claim":"Brd4 was shown to recruit the active (7SK/HEXIM1-free) form of P-TEFb to acetylated chromatin and stimulate CTD phosphorylation, establishing a recruitment mechanism linking histone acetylation to transcription elongation.","evidence":"Affinity purification-mass spectrometry, co-immunoprecipitation, ChIP, siRNA knockdown, transcription assays","pmids":["16109376"],"confidence":"Medium","gaps":["Whether Brd4 preferentially recruits CycT1- vs CycT2-containing P-TEFb was not resolved","The relative contribution of Brd4 vs other recruiters (e.g., MED26, Aire) at different loci was unknown"]},{"year":2008,"claim":"Determination of the crystal structure of free Cyclin T2 and the CDK9/CycT1 complex revealed C-type cyclin structural features and a distinctive CDK–cyclin interface rotation, providing a structural framework for understanding P-TEFb assembly and regulation.","evidence":"X-ray crystallography, in vitro kinase assays, mutagenesis","pmids":["18566585"],"confidence":"High","gaps":["A co-crystal of CDK9 bound to CycT2 (rather than CycT1) was not obtained","How the structural differences between CycT1 and CycT2 affect substrate selection remained unknown"]},{"year":2009,"claim":"Genetic ablation of Ccnt2 in mice demonstrated embryonic lethality and gene-expression profiling after knockdown in ES cells showed CycT1 and CycT2 regulate non-overlapping gene sets, establishing that the two P-TEFb cyclins are functionally non-redundant in vivo.","evidence":"Gene trap mutagenesis in mice, beta-galactosidase expression analysis, siRNA knockdown in embryonic stem cells, gene expression profiling","pmids":["19364821"],"confidence":"High","gaps":["The embryonic stage and developmental process at which lethality occurs was not precisely defined","Molecular basis of target gene selectivity between CycT1 and CycT2 was not determined"]},{"year":2011,"claim":"MED26 was identified as a Mediator subunit that acts as a molecular switch exchanging TFIID for SEC/P-TEFb at promoters, revealing a Mediator-dependent pathway for transition from initiation to elongation.","evidence":"Affinity purification-mass spectrometry, co-immunoprecipitation, ChIP, transcription assays","pmids":["21729782"],"confidence":"Medium","gaps":["Direct involvement of CycT2-containing P-TEFb in MED26-dependent recruitment was inferred but not specifically demonstrated","Whether MED26 acts genome-wide or at specific promoter classes was not resolved"]},{"year":2014,"claim":"An RNAi screen in thymic epithelial cells identified CCNT2 as a functional collaborator of Aire in driving ectopic autoantigen gene expression, with HNRNPL mediating 7SK/P-TEFb delivery to Aire-containing complexes — extending P-TEFb function to immune tolerance.","evidence":"Genome-scale lentiviral shRNA screen, RNA co-immunoprecipitation, lentigenic knockdown mice, flavopiridol treatment","pmids":["24434558"],"confidence":"Medium","gaps":["Whether CycT2-containing P-TEFb is specifically preferred over CycT1 in Aire-dependent transcription was not tested","The in vivo autoimmune phenotype upon CycT2-specific depletion in thymic epithelium was not assessed"]},{"year":2016,"claim":"CCNT2 was identified as a direct miR-297c-5p target controlling oligodendrocyte precursor differentiation and a miR-192 target promoting cell cycle progression in AML cells, demonstrating cell-type-specific P-TEFb functions regulated at the post-transcriptional level.","evidence":"Luciferase reporter assays, siRNA knockdown, lentiviral transduction, flow cytometry, rescue experiments in OPCs and NB4/HL-60 leukemia cells","pmids":["26843650","28409330"],"confidence":"Medium","gaps":["Whether miRNA-mediated CycT2 regulation shifts the CycT1/CycT2 ratio and alters P-TEFb target selectivity was not explored","In vivo relevance of these miRNA–CCNT2 axes in myelination or leukemogenesis was not established"]},{"year":2021,"claim":"CCNT2 was shown to occupy both the promoter and a distal enhancer of VEGFA and to control alternative splicing by modulating Pol II elongation rate, directly linking P-TEFb elongation kinetics to co-transcriptional splicing decisions.","evidence":"ChIP, siRNA silencing, RNA-seq and RT-PCR splice isoform analysis, RNAPII elongation rate measurement","pmids":["34316716"],"confidence":"Medium","gaps":["Whether CCNT2-dependent splicing regulation extends genome-wide or is locus-specific was not determined","The contribution of enhancer-bound CCNT2 versus promoter-bound CCNT2 to splicing regulation was not separated"]},{"year":null,"claim":"A major unresolved question is what determines CycT2 versus CycT1 target gene selectivity — whether it reflects differential chromatin recruitment, distinct protein interaction surfaces, or tissue-specific expression ratios.","evidence":"","pmids":[],"confidence":"High","gaps":["No genome-wide CycT2 ChIP-seq in comparison with CycT1 has been reported","Structural basis for any CycT2-specific protein interactions remains unknown","Conditional tissue-specific knockouts of CycT2 have not been characterized"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,1,2,3]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[7,11,13]}],"localization":[{"term_id":"GO:0005654","term_label":"nucleoplasm","supporting_discovery_ids":[4]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[4,7]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,1,5,8,13]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[10,12]},{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[1,2,3,13]}],"complexes":["P-TEFb (CDK9/CycT2)","7SK snRNP (inactive P-TEFb/HEXIM1/7SK)"],"partners":["CDK9","HEXIM1","BRD4","MED26","HNRNPL","AIRE"],"other_free_text":[]},"mechanistic_narrative":"CCNT2 (Cyclin T2) is the regulatory cyclin subunit of P-TEFb that partners with CDK9 in a mutually exclusive manner relative to Cyclin T1, conferring DRB-sensitive kinase activity that phosphorylates the RNA Pol II CTD to drive transcriptional elongation [PMID:9499409]. The majority of cellular CCNT2-containing P-TEFb is held inactive in a 7SK snRNA/HEXIM1 complex, from which it is released upon transcriptional stress to stimulate elongation; this equilibrium is regulated by Brd4 and MED26-mediated recruitment to chromatin [PMID:11713533, PMID:12832472, PMID:16109376, PMID:21729782]. Genetic ablation of Ccnt2 in mice causes embryonic lethality, and CCNT2 regulates non-redundant gene sets relative to Cyclin T1, including control of VEGFA alternative splicing through modulation of Pol II elongation rate, adipogenic gene expression, oligodendrocyte differentiation, and cell cycle progression in leukemia cells [PMID:19364821, PMID:34316716, PMID:27627980, PMID:26843650, PMID:28409330]."},"prefetch_data":{"uniprot":{"accession":"O60583","full_name":"Cyclin-T2","aliases":[],"length_aa":730,"mass_kda":81.0,"function":"Regulatory subunit of the cyclin-dependent kinase pair (CDK9/cyclin T) complex, also called positive transcription elongation factor B (P-TEFB), which is proposed to facilitate the transition from abortive to production elongation by phosphorylating the CTD (carboxy-terminal domain) of the large subunit of RNA polymerase II (RNAP II) (PubMed:15563843, PubMed:9499409). The activity of this complex is regulated by binding with 7SK snRNA (PubMed:11713533). Plays a role during muscle differentiation; P-TEFB complex interacts with MYOD1; this tripartite complex promotes the transcriptional activity of MYOD1 through its CDK9-mediated phosphorylation and binds the chromatin of promoters and enhancers of muscle-specific genes; this event correlates with hyperphosphorylation of the CTD domain of RNA pol II (By similarity). In addition, enhances MYOD1-dependent transcription through interaction with PKN1 (PubMed:16331689). Involved in early embryo development (By similarity) (Microbial infection) Promotes transcriptional activation of early and late herpes simplex virus 1/HHV-1 promoters","subcellular_location":"Cytoplasm, perinuclear region; Nucleus","url":"https://www.uniprot.org/uniprotkb/O60583/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CCNT2","classification":"Not Classified","n_dependent_lines":17,"n_total_lines":1208,"dependency_fraction":0.014072847682119206},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"CDK9","stoichiometry":0.2},{"gene":"LARP7","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/CCNT2","total_profiled":1310},"omim":[{"mim_id":"615695","title":"HEXAMETHYLENE BIS ACETAMIDE-INDUCIBLE PROTEIN 2; HEXIM2","url":"https://www.omim.org/entry/615695"},{"mim_id":"615657","title":"MICRO RNA 142; MIR142","url":"https://www.omim.org/entry/615657"},{"mim_id":"610782","title":"MICRO RNA 29A; MIR29A","url":"https://www.omim.org/entry/610782"},{"mim_id":"607328","title":"HEXAMETHYLENE BIS ACETAMIDE-INDUCIBLE PROTEIN 1; HEXIM1","url":"https://www.omim.org/entry/607328"},{"mim_id":"603862","title":"CYCLIN T2; CCNT2","url":"https://www.omim.org/entry/603862"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Cytosol","reliability":"Approved"},{"location":"Plasma membrane","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/CCNT2"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"O60583","domains":[{"cath_id":"1.10.472.10","chopping":"10-149","consensus_level":"medium","plddt":95.7727,"start":10,"end":149},{"cath_id":"1.10.472.10","chopping":"151-263","consensus_level":"medium","plddt":90.7386,"start":151,"end":263}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O60583","model_url":"https://alphafold.ebi.ac.uk/files/AF-O60583-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O60583-F1-predicted_aligned_error_v6.png","plddt_mean":58.91},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CCNT2","jax_strain_url":"https://www.jax.org/strain/search?query=CCNT2"},"sequence":{"accession":"O60583","fasta_url":"https://rest.uniprot.org/uniprotkb/O60583.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O60583/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O60583"}},"corpus_meta":[{"pmid":"24434558","id":"PMC_24434558","title":"An RNAi screen for Aire cofactors reveals a role for Hnrnpl in polymerase release and Aire-activated ectopic transcription.","date":"2014","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/24434558","citation_count":54,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19364821","id":"PMC_19364821","title":"Cyclin T2 is essential for mouse embryogenesis.","date":"2009","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19364821","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28409330","id":"PMC_28409330","title":"MicroRNA-192 regulates cell proliferation and cell cycle transition in acute myeloid leukemia via interaction with CCNT2.","date":"2017","source":"International journal of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/28409330","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26843650","id":"PMC_26843650","title":"Remyelinating Oligodendrocyte Precursor Cell miRNAs from the Sfmbt2 Cluster Promote Cell Cycle Arrest and Differentiation.","date":"2016","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/26843650","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27627980","id":"PMC_27627980","title":"Epigenetic programming of adipose-derived stem cells in low birthweight individuals.","date":"2016","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/27627980","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21740905","id":"PMC_21740905","title":"Cyclin T2: a novel miR-15a target gene involved in early spermatogenesis.","date":"2011","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/21740905","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29849811","id":"PMC_29849811","title":"Downregulation of microRNA-142-3p and its tumor suppressor role in gastric cancer.","date":"2018","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/29849811","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37020690","id":"PMC_37020690","title":"Nanoparticles Mediated circROBO1 Silencing to Inhibit Hepatocellular Carcinoma Progression by Modulating miR-130a-5p/CCNT2 Axis.","date":"2023","source":"International journal of nanomedicine","url":"https://pubmed.ncbi.nlm.nih.gov/37020690","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35581549","id":"PMC_35581549","title":"Genome-wide detection of genetic structure and runs of homozygosity analysis in Anhui indigenous and Western commercial pig breeds using PorcineSNP80k data.","date":"2022","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/35581549","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26277788","id":"PMC_26277788","title":"Targeting polyamine biosynthetic pathway through RNAi causes the abrogation of MCF 7 breast cancer cell line.","date":"2015","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26277788","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31911195","id":"PMC_31911195","title":"Hypothalamic proteome changes in response to nicotine and its withdrawal are potentially associated with alteration in body weight.","date":"2020","source":"Journal of proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/31911195","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33574088","id":"PMC_33574088","title":"Smoking Modifies Pancreatic Cancer Risk Loci on 2q21.3.","date":"2021","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/33574088","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27650971","id":"PMC_27650971","title":"Ancestry-based stratified analysis of Immunochip data identifies novel associations with celiac disease.","date":"2016","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/27650971","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33600051","id":"PMC_33600051","title":"Restoration of NRF2 attenuates myocardial ischemia reperfusion injury through mediating microRNA-29a-3p/CCNT2 axis.","date":"2021","source":"BioFactors (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/33600051","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31957815","id":"PMC_31957815","title":"MiRNA-188-5p alleviates the progression of osteosarcoma via target degrading CCNT2.","date":"2020","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31957815","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32441300","id":"PMC_32441300","title":"Potential role of miR-155-5p in fat deposition and skeletal muscle development of chicken.","date":"2020","source":"Bioscience reports","url":"https://pubmed.ncbi.nlm.nih.gov/32441300","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37866126","id":"PMC_37866126","title":"Enlightening the path to NSCLC biomarkers: Utilizing the power of XAI-guided deep learning.","date":"2023","source":"Computer methods and programs in biomedicine","url":"https://pubmed.ncbi.nlm.nih.gov/37866126","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26708993","id":"PMC_26708993","title":"Genetic variants in cell cycle control pathway confer susceptibility to aggressive prostate carcinoma.","date":"2015","source":"The Prostate","url":"https://pubmed.ncbi.nlm.nih.gov/26708993","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35012431","id":"PMC_35012431","title":"Long non-coding RNA nuclear-enriched abundant transcript 1 (LncRNA NEAT1) upregulates Cyclin T2 (CCNT2) in laryngeal papilloma through sponging miR-577/miR-1224-5p and blocking cell apoptosis.","date":"2022","source":"Bioengineered","url":"https://pubmed.ncbi.nlm.nih.gov/35012431","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34316716","id":"PMC_34316716","title":"VEGFA's distal enhancer regulates its alternative splicing in CML.","date":"2021","source":"NAR cancer","url":"https://pubmed.ncbi.nlm.nih.gov/34316716","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35847642","id":"PMC_35847642","title":"Genome-Wide Detection of Copy Number Variations and Evaluation of Candidate Copy Number Polymorphism Genes Associated With Complex Traits of Pigs.","date":"2022","source":"Frontiers in veterinary science","url":"https://pubmed.ncbi.nlm.nih.gov/35847642","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38215789","id":"PMC_38215789","title":"Identifying BMI-associated genes via a genome-wide multi-omics integrative approach using summary data.","date":"2024","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/38215789","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38887684","id":"PMC_38887684","title":"Circ_0007386 Promotes the Progression of Hepatocellular Carcinoma Through the miR-507/ CCNT2 Axis.","date":"2024","source":"Journal of hepatocellular carcinoma","url":"https://pubmed.ncbi.nlm.nih.gov/38887684","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38352277","id":"PMC_38352277","title":"Genetic Alterations in Invasive Breast Carcinoma with a Glycogen-Rich Clear Cell Pattern: A Case Report.","date":"2021","source":"Case reports in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/38352277","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33817287","id":"PMC_33817287","title":"Decitabine shows anti-acute myeloid leukemia potential via regulating the miR-212-5p/CCNT2 axis.","date":"2020","source":"Open life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33817287","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30418981","id":"PMC_30418981","title":"Short-lived AUF1 p42-binding mRNAs of RANKL and BCL6 have two distinct instability elements each.","date":"2018","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/30418981","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"42040470","id":"PMC_42040470","title":"RNA-Binding Proteins Alter Redox Gene Splicing in Biliary Atresia: Insights from Expression Profiling.","date":"2026","source":"ACS omega","url":"https://pubmed.ncbi.nlm.nih.gov/42040470","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41761439","id":"PMC_41761439","title":"Expanding the Morphological, Immunohistochemical, and Molecular Spectrums of NUT Carcinoma at Rare Sites of Head and Neck Region.","date":"2026","source":"Oral diseases","url":"https://pubmed.ncbi.nlm.nih.gov/41761439","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15302935","id":"PMC_15302935","title":"Large-scale characterization of HeLa cell nuclear phosphoproteins.","date":"2004","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15302935","citation_count":1159,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16109376","id":"PMC_16109376","title":"The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription.","date":"2005","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/16109376","citation_count":1075,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14702039","id":"PMC_14702039","title":"Complete sequencing and characterization of 21,243 full-length human cDNAs.","date":"2003","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14702039","citation_count":754,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11713533","id":"PMC_11713533","title":"7SK small nuclear RNA binds to and inhibits the activity of CDK9/cyclin T complexes.","date":"2001","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/11713533","citation_count":576,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9499409","id":"PMC_9499409","title":"Identification of multiple cyclin subunits of human P-TEFb.","date":"1998","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/9499409","citation_count":463,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35271311","id":"PMC_35271311","title":"OpenCell: Endogenous tagging for the cartography of human cellular organization.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35271311","citation_count":432,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16344560","id":"PMC_16344560","title":"Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.","date":"2005","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/16344560","citation_count":409,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26344197","id":"PMC_26344197","title":"Panorama of ancient metazoan macromolecular complexes.","date":"2015","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/26344197","citation_count":407,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17643375","id":"PMC_17643375","title":"Systematic analysis of the protein interaction network for the human transcription machinery reveals the identity of the 7SK capping enzyme.","date":"2007","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/17643375","citation_count":367,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18566585","id":"PMC_18566585","title":"The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation.","date":"2008","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/18566585","citation_count":304,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21729782","id":"PMC_21729782","title":"Human mediator subunit MED26 functions as a docking site for transcription elongation factors.","date":"2011","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/21729782","citation_count":281,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15201869","id":"PMC_15201869","title":"Binding of the 7SK snRNA turns the HEXIM1 protein into a P-TEFb (CDK9/cyclin T) inhibitor.","date":"2004","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/15201869","citation_count":266,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12832472","id":"PMC_12832472","title":"MAQ1 and 7SK RNA interact with CDK9/cyclin T complexes in a transcription-dependent manner.","date":"2003","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12832472","citation_count":211,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12676794","id":"PMC_12676794","title":"The RNA polymerase II elongation complex.","date":"2003","source":"Annual review of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12676794","citation_count":194,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32203420","id":"PMC_32203420","title":"Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.","date":"2020","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/32203420","citation_count":194,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23602568","id":"PMC_23602568","title":"The protein interaction landscape of the human CMGC kinase group.","date":"2013","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/23602568","citation_count":174,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23455922","id":"PMC_23455922","title":"Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS.","date":"2013","source":"Nature methods","url":"https://pubmed.ncbi.nlm.nih.gov/23455922","citation_count":170,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32807901","id":"PMC_32807901","title":"UFMylation maintains tumour suppressor p53 stability by antagonizing its ubiquitination.","date":"2020","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/32807901","citation_count":168,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32416067","id":"PMC_32416067","title":"Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.","date":"2020","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/32416067","citation_count":159,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19322201","id":"PMC_19322201","title":"Ubiquitin-mediated proteolysis of HuR by heat shock.","date":"2009","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/19322201","citation_count":142,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30554943","id":"PMC_30554943","title":"Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.","date":"2018","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/30554943","citation_count":136,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29117863","id":"PMC_29117863","title":"RNA-binding activity of TRIM25 is mediated by its PRY/SPRY domain and is required for ubiquitination.","date":"2017","source":"BMC biology","url":"https://pubmed.ncbi.nlm.nih.gov/29117863","citation_count":135,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11282025","id":"PMC_11282025","title":"The Cdk9 and cyclin T subunits of TAK/P-TEFb localize to splicing factor-rich nuclear speckle regions.","date":"2001","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/11282025","citation_count":115,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18029348","id":"PMC_18029348","title":"Toward a confocal subcellular atlas of the human proteome.","date":"2007","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/18029348","citation_count":114,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":16926,"output_tokens":2214,"usd":0.041994},"stage2":{"model":"claude-opus-4-6","input_tokens":5506,"output_tokens":2626,"usd":0.13977},"total_usd":0.434558,"stage1_batch_id":"msgbatch_011kfMfE81o6CTcyhVUqumuW","stage2_batch_id":"msgbatch_01DTputS6WNkH745x1nVSoBo","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":28984,"output_tokens":4160,"usd":0.074676},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":7824,"output_tokens":3185,"usd":0.178118}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2009,\n      \"finding\": \"CycT2 (CCNT2) forms part of the P-TEFb complex with CDK9 and is essential for transcriptional elongation by RNA polymerase II; genetic inactivation of Ccnt2 in mice via gene trap causes early embryonic lethality, demonstrating that CycT1 and CycT2 regulate distinct, non-redundant subsets of genes required for embryonic development.\",\n      \"method\": \"Gene trap knockout mouse, beta-galactosidase reporter, siRNA knockdown in embryonic stem cells\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined developmental phenotype, siRNA knockdown with gene expression readout, replicated across multiple organismal and cellular systems\",\n      \"pmids\": [\"19364821\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"CCNT2, as a component of P-TEFb, functions as a cofactor for Aire-activated transcription by facilitating release of paused RNA polymerases; CCNT2 was identified in Aire-containing complexes together with CDK9, HEXIM1, and 7SK RNA, and its knockdown reduced Aire-dependent gene expression.\",\n      \"method\": \"Genome-scale lentiviral shRNA screen, co-immunoprecipitation of CCNT2 with CDK9/HEXIM1/7SK RNA, lentigenic knockdown mice, flavopiridol inhibitor experiments\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP demonstrating complex membership, functional KD with defined transcriptional phenotype, validated in vivo in knockdown mice\",\n      \"pmids\": [\"24434558\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"CCNT2 binds both the promoter and the distal +157 enhancer of VEGFA, and its silencing slows RNA polymerase II elongation rate, promoting exclusion of VEGFA exons 6a and 7, thus linking CCNT2-mediated elongation to alternative splicing regulation.\",\n      \"method\": \"ChIP (chromatin immunoprecipitation) of CCNT2 at VEGFA promoter and enhancer; siRNA-mediated silencing of CCNT2 with splicing readout by RT-PCR\",\n      \"journal\": \"NAR cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP demonstrating direct binding plus KD with defined splicing phenotype, single lab study\",\n      \"pmids\": [\"34316716\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"CCNT2 silencing in human adipocytes decreases leptin secretion and reduces mRNA expression of adipogenesis genes (MGLL, LIPE, PPARG, LEP, ADIPOQ), establishing CCNT2 as a transcriptional regulator of adipogenic gene programs.\",\n      \"method\": \"siRNA knockdown of CCNT2 in human adipocytes, qRT-PCR, leptin secretion assay\",\n      \"journal\": \"Diabetologia\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean KD with defined cellular phenotype, single lab but multiple gene expression readouts\",\n      \"pmids\": [\"27627980\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"CCNT2 (the regulatory subunit of P-TEFb) functions as an inhibitor of oligodendrocyte maturation; CCNT2-specific knockdown promoted rat oligodendrocyte progenitor cell differentiation without affecting cell cycle status, and CCNT2 was validated as a direct target of miR-297c-5p by luciferase reporter assay.\",\n      \"method\": \"siRNA knockdown of CCNT2 in rat OPCs, luciferase reporter assay, flow cytometry, immunostaining for O1+ marker\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KD with defined differentiation phenotype plus luciferase validation of targeting, single lab\",\n      \"pmids\": [\"26843650\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"CCNT2 promotes cell cycle progression in acute myeloid leukemia cells; exogenous CCNT2 expression attenuated G0/G1 arrest induced by miR-192, and miR-192 directly targets the CCNT2 3'-UTR as confirmed by dual-luciferase reporter assay.\",\n      \"method\": \"Dual-luciferase reporter assay, qRT-PCR, Western blot, flow cytometry, rescue overexpression experiment\",\n      \"journal\": \"International journal of hematology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — luciferase validation plus rescue experiment, single lab\",\n      \"pmids\": [\"28409330\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"CCNT2 (Cyclin T2) was confirmed as a direct target of miR-15a in mouse testes, with inverse correlation of miR-15a and Ccnt2 during postnatal spermatogenesis; miR-15a inhibited muscle differentiation at least partly by targeting Ccnt2.\",\n      \"method\": \"Luciferase reporter assay, qRT-PCR profiling of miR-15a and Ccnt2 in developing mouse testes, functional differentiation assay\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — luciferase validation plus in vivo correlation, single lab\",\n      \"pmids\": [\"21740905\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"NRF2 transcriptionally activates miR-29a-3p (verified by ChIP), which in turn targets and suppresses CCNT2 (verified by dual-luciferase reporter); the NRF2/miR-29a-3p/CCNT2 axis modulates cardiomyocyte apoptosis and myocardial ischemia-reperfusion injury.\",\n      \"method\": \"ChIP assay (NRF2 at miR-29a-3p promoter), dual-luciferase reporter assay (miR-29a-3p targeting CCNT2 3'UTR), rat MI/RI model with plasmid overexpression, H/R cardiomyocyte model\",\n      \"journal\": \"BioFactors\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP and luciferase in orthogonal assays establishing pathway hierarchy, single lab\",\n      \"pmids\": [\"33600051\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"CCNT2 mRNA was identified as an unstable AUF1 p42-binding target, placing CCNT2 mRNA stability under regulation by the AU-rich element binding protein AUF1 p42.\",\n      \"method\": \"RNA-protein co-immunoprecipitation using myc-AUF1 p42, Affymetrix microarray of bound mRNAs\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single co-IP/pulldown approach, no functional follow-up on CCNT2 specifically\",\n      \"pmids\": [\"30418981\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CCNT2 (Cyclin T2) is a regulatory cyclin subunit of the P-TEFb complex (with CDK9) that is essential for transcriptional elongation by RNA polymerase II, non-redundantly regulating distinct gene subsets from CycT1-containing P-TEFb; it participates in Aire-dependent release of paused polymerases in thymic epithelial cells, binds VEGFA regulatory elements to couple elongation rate to alternative splicing, promotes cell cycle progression and inhibits oligodendrocyte maturation, and is required for embryonic development and adipogenic transcriptional programs—with its activity regulated post-transcriptionally by multiple miRNAs targeting its 3'-UTR and at the mRNA stability level by AUF1.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"Human P-TEFb contains multiple cyclin subunits including Cyclin T1, Cyclin T2a, and Cyclin T2b (the latter two arising from alternative splicing of CCNT2). Cyclin T1 and T2 associate with CDK9 in a mutually exclusive manner, and almost all CDK9 is associated with either cyclin T1 or T2. Recombinant CDK9/CycT2a and CDK9/CycT2b complexes produced in Sf9 cells possess DRB-sensitive kinase activity and function in transcription elongation in vitro; truncation of the cyclin C-terminus reduces but does not eliminate P-TEFb activity.\",\n      \"method\": \"Immunoprecipitation, immunodepletion from HeLa nuclear extract, recombinant protein production in Sf9 cells, in vitro kinase assays, in vitro transcription elongation assays, cotransfection\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro with functional assays, multiple orthogonal methods\",\n      \"pmids\": [\"9499409\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"In human HeLa cells, more than half of P-TEFb (containing CDK9 and Cyclin T1 or T2) is sequestered in larger complexes also containing 7SK snRNA. The 7SK/P-TEFb complex shows very weak kinase activity compared to the smaller active P-TEFb complexes. Inhibition of transcription by chemical agents or UV irradiation triggers disruption of the P-TEFb/7SK complex and enhances CDK9 activity, indicating a feedback loop modulating RNA Pol II activity.\",\n      \"method\": \"Immunoprecipitation, sucrose gradient sedimentation, in vitro kinase assays, chemical inhibitor and UV treatment\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods, foundational paper replicated by subsequent work\",\n      \"pmids\": [\"11713533\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"MAQ1 (HEXIM1) is a novel component of the inactive P-TEFb complex containing CDK9, Cyclin T1 or T2, and 7SK snRNA. MAQ1 binds directly to the N-terminal cyclin homology region of both Cyclin T1 and Cyclin T2 (by yeast two-hybrid and immunoprecipitation), and 7SK RNA is required for MAQ1 to associate with P-TEFb. The MAQ1/7SK complex competes with HIV Tat binding to Cyclin T1.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation from transfected cell extracts, immunoprecipitation of endogenous complexes\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP plus yeast two-hybrid, replicated across labs\",\n      \"pmids\": [\"12832472\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"HEXIM1 (MAQ1) binding to 7SK snRNA is required to convert HEXIM1 into a P-TEFb (CDK9/Cyclin T) inhibitor. In vitro reconstitution demonstrated 7SK-dependent HEXIM1 association to purified P-TEFb and subsequent CDK9 inhibition. A 7SK RNA-recognition motif was identified in the central part of HEXIM1 (aa 152–155) and direct P-TEFb binding to HEXIM1 C-terminal domain (aa 181–359) was mapped; mutations in a conserved motif (aa 202–205) suppress P-TEFb binding without affecting 7SK recognition.\",\n      \"method\": \"In vitro reconstitution of purified components, yeast three-hybrid, gel-shift assays, GST pull-down, point mutagenesis\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with purified components plus mutagenesis\",\n      \"pmids\": [\"15201869\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"CDK9 and Cyclin T1 (and by extension P-TEFb complexes) localize throughout the non-nucleolar nucleoplasm and concentrate at nuclear speckles enriched in splicing factors. A central region of Cyclin T1 is important for speckle accumulation, and Cyclin T1 can recruit CDK9 and HIV Tat to this compartment. Treatment with transcription inhibitors alters the distribution of CDK9 and Cyclin T1, linking their localization to active transcription.\",\n      \"method\": \"High-resolution immunofluorescence microscopy, co-localization with splicing factor markers, transient expression of deletion mutants\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct localization with functional mutants; primarily Cyclin T1, CycT2 localization inferred by complex membership\",\n      \"pmids\": [\"11282025\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Brd4 interacts with the active (HEXIM1/7SK-free) form of P-TEFb, which contains Cyclin T1 and CDK9, and stimulates P-TEFb-dependent phosphorylation of the RNA Pol II CTD and transcription. Reducing Brd4 by siRNA decreases CTD phosphorylation; ChIP shows Brd4-dependent recruitment of P-TEFb to promoters enhanced by increased chromatin acetylation.\",\n      \"method\": \"Proteomic analysis, co-immunoprecipitation, siRNA knockdown, ChIP, in vivo transcription assays\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods; focus is on CycT1-containing P-TEFb; CCNT2 involvement inferred via complex\",\n      \"pmids\": [\"16109376\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Crystal structure of free Cyclin T2 was determined, revealing structural features of C-type cyclins. CDK9/CycT1 structure shows a 26° rotation of CycT1 relative to CDK9 compared with CDK2/CycA, demonstrating plasticity in CDK-cyclin interfaces. CDK9 autophosphorylates on Thr186 in the activation segment and three C-terminal sites; autophosphorylation on all sites occurs in cis and governs CDK9 activity and recognition of regulatory proteins.\",\n      \"method\": \"X-ray crystallography, in vitro kinase assay, mutagenesis\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure of free CycT2 plus CDK9/CycT1 structure with functional validation\",\n      \"pmids\": [\"18566585\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Genetic inactivation of the Ccnt2 gene (using beta-geo gene trap) in mice is embryonic lethal; no CycT2−/− embryos are recovered despite numerous heterozygous matings. CycT2 is expressed abundantly throughout embryogenesis and in all adult tissues. siRNA knockdown of CycT2 in embryonic stem cells identifies critical target genes, demonstrating that CycT1 and CycT2 regulate distinct subsets of genes and are not functionally redundant.\",\n      \"method\": \"Gene trap mutagenesis in mice, beta-galactosidase reporter expression analysis, siRNA knockdown in embryonic stem cells, gene expression analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic KO with defined lethal phenotype, replicated over multiple crosses, combined with cellular knockdown\",\n      \"pmids\": [\"19364821\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"MED26, a Mediator subunit, contains overlapping docking sites in its conserved N-terminal domain for super-elongation complexes (SECs) containing ELL/EAF family members and P-TEFb (which includes Cyclin T subunits), as well as TFIID. MED26 can act as a molecular switch, first interacting with TFIID during initiation then exchanging for SEC/P-TEFb complexes to facilitate Pol II transition into elongation.\",\n      \"method\": \"Co-immunoprecipitation, affinity purification-mass spectrometry, ChIP, functional transcription assays\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple methods, but CCNT2 involvement is inferred through P-TEFb complex membership\",\n      \"pmids\": [\"21729782\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"An RNAi screen identified CCNT2 (component of P-TEFb) as a functional ally of Aire in thymic epithelial cells for ectopic transcription of autoantigen genes. HNRNPL interacts directly with P-TEFb components CDK9, CCNT2, HEXIM1, and 7SK RNA, and Aire-containing complexes include 7SK RNA. HNRNPL knockdown disrupts 7SK RNA interaction with Aire-containing complexes, suggesting HNRNPL participates in delivering inactive P-TEFb to Aire to release stalled polymerases.\",\n      \"method\": \"Genome-scale lentiviral shRNA screen, RNA co-immunoprecipitation, lentigenic knockdown mice, flavopiridol inhibitor treatment, qRT-PCR\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — RNAi screen validated with multiple orthogonal methods including Co-IP and in vivo knockdown mice\",\n      \"pmids\": [\"24434558\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"CCNT2 (the regulatory subunit of P-TEFb) is a direct functional target of miR-297c-5p in oligodendrocyte precursor cells (OPCs). Luciferase reporter assays confirmed miR-297c-5p targets CCNT2; CCNT2-specific knockdown promoted rOPC differentiation (increased O1+ cells) without affecting cell cycle status, while miR-297c-5p overexpression caused both G1/G0 arrest and enhanced differentiation. This places CCNT2 as an inhibitor of oligodendrocyte maturation.\",\n      \"method\": \"Luciferase reporter assay, lentiviral transduction, flow cytometry, immunostaining, siRNA knockdown\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — luciferase validation plus functional knockdown with specific differentiation phenotype\",\n      \"pmids\": [\"26843650\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Silencing of CCNT2 in human adipocytes decreased leptin secretion and reduced mRNA expression of adipogenesis-related genes including MGLL, LIPE, PPARG, LEP, and ADIPOQ, establishing CCNT2 as a transcriptional regulator required for normal adipogenic gene expression.\",\n      \"method\": \"siRNA knockdown in human adipocytes, ELISA (leptin secretion), qRT-PCR\",\n      \"journal\": \"Diabetologia\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single-lab siRNA knockdown with defined gene expression phenotype\",\n      \"pmids\": [\"27627980\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"miR-192 directly targets the 3'-UTR of CCNT2 (confirmed by dual-luciferase reporter assay with wild-type vs. mutated 3'-UTR), downregulates CCNT2 protein, and overexpression of CCNT2 attenuates miR-192-induced G0/G1 cell cycle arrest in NB4 and HL-60 AML cells, establishing CCNT2 as a functional driver of cell cycle progression in leukemia cells.\",\n      \"method\": \"Dual-luciferase reporter assay, qRT-PCR, Western blot, flow cytometry, rescue experiments with CCNT2 overexpression\",\n      \"journal\": \"International journal of hematology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — luciferase validation plus rescue experiment with specific cell cycle phenotype\",\n      \"pmids\": [\"28409330\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"CCNT2 binds to both the promoter and the +157 distal enhancer of VEGFA (shown by ChIP), and CCNT2 silencing promotes exclusion of VEGFA exons 6a and 7 by slowing RNA Pol II elongation rate, demonstrating that CCNT2 regulates alternative splicing of VEGFA through its role in controlling transcription elongation speed.\",\n      \"method\": \"ChIP, siRNA silencing, RNA-seq/RT-PCR splice isoform analysis, RNAPII elongation rate measurement\",\n      \"journal\": \"NAR cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP plus functional silencing with defined splicing phenotype, mechanistically linked to elongation rate\",\n      \"pmids\": [\"34316716\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"NRF2 transcriptionally activates miR-29a-3p (confirmed by ChIP), which in turn directly targets and suppresses CCNT2 (validated by dual-luciferase reporter assay). In rat myocardial ischemia/reperfusion injury models, CCNT2 is upregulated while NRF2 and miR-29a-3p are downregulated; restoration of NRF2 or miR-29a-3p reduces CCNT2 levels, improving hemodynamics and reducing cardiomyocyte apoptosis via the NRF2/miR-29a-3p/CCNT2 axis.\",\n      \"method\": \"ChIP (NRF2 binding to miR-29a-3p promoter), dual-luciferase reporter assay, rat MI/RI model, H/R cell model, plasmid overexpression, flow cytometry, Western blot\",\n      \"journal\": \"BioFactors\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — multiple orthogonal methods including ChIP and in vivo model with functional readouts\",\n      \"pmids\": [\"33600051\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CCNT2 encodes Cyclin T2, the regulatory subunit of the positive transcription elongation factor b (P-TEFb) complex (together with CDK9), which phosphorylates the RNA Pol II CTD to promote transcriptional elongation; CCNT2-containing P-TEFb is held in an inactive state by 7SK snRNA/HEXIM1, is recruited to promoters and enhancers to control elongation rate and alternative splicing, is essential for mouse embryogenesis (with non-redundant functions relative to Cyclin T1), and regulates cell cycle progression and differentiation in multiple cell types including oligodendrocyte precursors, leukemia cells, and adipocytes.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"CCNT2 (Cyclin T2) is a regulatory cyclin subunit of the positive transcription elongation factor b (P-TEFb) complex that partners with CDK9 to drive RNA polymerase II elongation, controlling non-redundant gene programs essential for embryonic development, adipogenesis, and immune tolerance [PMID:19364821, PMID:27627980, PMID:24434558]. CCNT2-containing P-TEFb is recruited to Aire-dependent loci in thymic epithelial cells, where it releases paused polymerases to enable promiscuous gene expression required for central tolerance, and it binds VEGFA regulatory elements to couple elongation rate with alternative splicing decisions [PMID:24434558, PMID:34316716]. CCNT2 promotes cell cycle progression and inhibits oligodendrocyte progenitor differentiation, and its expression is tightly regulated post-transcriptionally by multiple miRNAs (miR-15a, miR-192, miR-29a-3p, miR-297c-5p) targeting its 3′-UTR [PMID:28409330, PMID:26843650, PMID:21740905, PMID:33600051]. Genetic inactivation of Ccnt2 in mice causes early embryonic lethality, demonstrating that CycT1 cannot compensate for CycT2 during development [PMID:19364821].\",\n  \"teleology\": [\n    {\n      \"year\": 2009,\n      \"claim\": \"Establishing that CCNT2 is a non-redundant P-TEFb subunit essential for embryonic viability answered whether CycT1 and CycT2 serve interchangeable roles and revealed that each controls distinct gene subsets.\",\n      \"evidence\": \"Gene-trap knockout in mice producing early embryonic lethality; siRNA knockdown in ES cells showing distinct transcriptional targets\",\n      \"pmids\": [\"19364821\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Identity of the specific gene subsets uniquely regulated by CycT2 versus CycT1 remains unresolved\",\n        \"Mechanism determining promoter selectivity between CycT1- and CycT2-containing P-TEFb is unknown\",\n        \"Whether CycT2 loss affects CDK9 stability or redirects it to CycT1 was not assessed\"\n      ]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Identification of CCNT2 as a direct miR-15a target during spermatogenesis established the principle that CCNT2 levels are post-transcriptionally tuned by miRNAs in a tissue- and developmental-stage–specific manner.\",\n      \"evidence\": \"Luciferase reporter assay confirming miR-15a targeting of Ccnt2 3′-UTR; inverse expression profiling in developing mouse testes\",\n      \"pmids\": [\"21740905\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Functional consequence of miR-15a–mediated CCNT2 suppression on spermatogenesis was not directly tested\",\n        \"Whether miR-15a affects CycT2 protein levels in vivo was not shown\"\n      ]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Demonstrating that CCNT2/P-TEFb is a cofactor for Aire-dependent transcription answered how Aire activates promiscuous gene expression, revealing it does so by releasing paused RNA polymerases through P-TEFb recruitment.\",\n      \"evidence\": \"Genome-scale shRNA screen, co-immunoprecipitation of CCNT2 with CDK9/HEXIM1/7SK RNA, in vivo validation in lentigenic knockdown mice, flavopiridol inhibitor experiments\",\n      \"pmids\": [\"24434558\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether Aire directly recruits CCNT2-P-TEFb or acts through an intermediary bridging factor is unresolved\",\n        \"Relative contribution of CycT2- versus CycT1-containing P-TEFb to Aire-dependent transcription was not fully delineated\"\n      ]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Showing that CCNT2 knockdown promotes oligodendrocyte differentiation and that CCNT2 silencing reduces adipogenic gene expression revealed cell-type–specific roles for CCNT2 beyond general elongation, acting as a differentiation brake in neural progenitors and a transcriptional activator of adipogenesis.\",\n      \"evidence\": \"siRNA knockdown in rat OPCs with differentiation markers (oligodendrocyte study); siRNA knockdown in human adipocytes with qRT-PCR of PPARG, LEP, ADIPOQ (adipogenesis study)\",\n      \"pmids\": [\"26843650\", \"27627980\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Genome-wide target genes mediating CCNT2's differentiation-inhibitory effect in OPCs are not identified\",\n        \"Whether CCNT2 directly occupies adipogenic gene promoters was not tested\",\n        \"In vivo relevance of CCNT2 in adipose tissue or myelination has not been demonstrated\"\n      ]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Rescue experiments showing that exogenous CCNT2 overcomes miR-192–induced G0/G1 arrest in AML cells established CCNT2 as a functionally relevant cell cycle promoter downstream of miRNA regulation in leukemia.\",\n      \"evidence\": \"Dual-luciferase reporter assay, CCNT2 overexpression rescue of miR-192–induced arrest, flow cytometry in AML cells\",\n      \"pmids\": [\"28409330\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether CCNT2's cell-cycle role operates through CDK9-dependent phosphorylation of specific substrates was not addressed\",\n        \"Relevance to AML patient prognosis or in vivo leukemia models was not tested\"\n      ]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Identification of CCNT2 mRNA as an AUF1 p42-bound target introduced an additional layer of post-transcriptional regulation via mRNA stability control.\",\n      \"evidence\": \"RNA co-immunoprecipitation with myc-AUF1 p42 followed by microarray identification\",\n      \"pmids\": [\"30418981\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No functional follow-up demonstrating that AUF1 binding alters CCNT2 mRNA half-life or protein output\",\n        \"Single co-IP approach without reciprocal or orthogonal validation for CCNT2 specifically\",\n        \"Physiological context in which AUF1-mediated CCNT2 regulation is relevant is unknown\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"ChIP-validated binding of CCNT2 at the VEGFA promoter and enhancer, coupled with the finding that its silencing slows elongation and alters splicing, established a direct mechanistic link between P-TEFb elongation rate and co-transcriptional alternative splicing decisions.\",\n      \"evidence\": \"ChIP of CCNT2 at VEGFA locus; siRNA silencing with RT-PCR splicing readout\",\n      \"pmids\": [\"34316716\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether CCNT2-dependent kinetic coupling of elongation and splicing generalizes beyond VEGFA is untested\",\n        \"The mechanism by which CCNT2 is recruited to the distal enhancer element is unknown\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Placing CCNT2 downstream of the NRF2/miR-29a-3p axis in cardiomyocyte ischemia-reperfusion injury expanded the regulatory network controlling CCNT2 and linked its suppression to apoptosis modulation in the heart.\",\n      \"evidence\": \"ChIP of NRF2 at miR-29a-3p promoter; dual-luciferase assay for miR-29a-3p targeting CCNT2; rat MI/RI and H/R cardiomyocyte models\",\n      \"pmids\": [\"33600051\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether CCNT2 suppression directly mediates the anti-apoptotic effect or acts through downstream elongation targets is unclear\",\n        \"In vivo cardiac phenotype of CCNT2 modulation independent of the miR-29a-3p axis was not assessed\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The promoter selectivity mechanism distinguishing CycT2- from CycT1-containing P-TEFb, the genome-wide direct transcriptional targets of CCNT2, and whether CCNT2's differentiation and splicing roles are CDK9-kinase-dependent remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No genome-wide CycT2 versus CycT1 occupancy comparison exists\",\n        \"No structural model of CycT2-specific promoter recognition has been produced\",\n        \"Whether kinase-dead CDK9 phenocopies CCNT2 loss in splicing or differentiation contexts is untested\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 1, 2, 4, 5]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [1, 2]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 1, 2, 3]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [5]},\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"complexes\": [\n      \"P-TEFb\"\n    ],\n    \"partners\": [\n      \"CDK9\",\n      \"HEXIM1\",\n      \"AIRE\",\n      \"AUF1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"CCNT2 (Cyclin T2) is the regulatory cyclin subunit of P-TEFb that partners with CDK9 in a mutually exclusive manner relative to Cyclin T1, conferring DRB-sensitive kinase activity that phosphorylates the RNA Pol II CTD to drive transcriptional elongation [PMID:9499409]. The majority of cellular CCNT2-containing P-TEFb is held inactive in a 7SK snRNA/HEXIM1 complex, from which it is released upon transcriptional stress to stimulate elongation; this equilibrium is regulated by Brd4 and MED26-mediated recruitment to chromatin [PMID:11713533, PMID:12832472, PMID:16109376, PMID:21729782]. Genetic ablation of Ccnt2 in mice causes embryonic lethality, and CCNT2 regulates non-redundant gene sets relative to Cyclin T1, including control of VEGFA alternative splicing through modulation of Pol II elongation rate, adipogenic gene expression, oligodendrocyte differentiation, and cell cycle progression in leukemia cells [PMID:19364821, PMID:34316716, PMID:27627980, PMID:26843650, PMID:28409330].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Identification of Cyclin T2a and T2b as alternative splice-derived regulatory subunits of P-TEFb established that CDK9 partners with multiple cyclins to drive transcription elongation, resolving the molecular composition of the complex.\",\n      \"evidence\": \"Immunoprecipitation, recombinant protein reconstitution in Sf9 cells, in vitro kinase and transcription elongation assays in HeLa nuclear extracts\",\n      \"pmids\": [\"9499409\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether CycT2a and CycT2b have distinct substrate specificities or gene targets was not addressed\",\n        \"In vivo functional distinction between CycT1- and CycT2-containing P-TEFb remained unknown\"\n      ]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Discovery that 7SK snRNA sequesters >50% of P-TEFb (including CycT2-containing forms) into inactive high-molecular-weight complexes revealed a major regulatory layer controlling elongation capacity, with stress-induced release as a feedback mechanism.\",\n      \"evidence\": \"Sucrose gradient sedimentation, co-immunoprecipitation, in vitro kinase assays with chemical inhibitor and UV treatment in HeLa cells\",\n      \"pmids\": [\"11713533\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"The protein factor(s) mediating P-TEFb inhibition within the 7SK complex had not yet been identified\",\n        \"The stoichiometry of CycT2-containing vs CycT1-containing inactive complexes was not determined\"\n      ]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Identification of HEXIM1 as the direct inhibitory protein within the 7SK/P-TEFb complex, binding the cyclin homology region of both CycT1 and CycT2, resolved how 7SK-dependent inhibition is executed at the molecular level.\",\n      \"evidence\": \"Yeast two-hybrid, co-immunoprecipitation of endogenous and transfected complexes\",\n      \"pmids\": [\"12832472\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"The structural basis of HEXIM1–Cyclin T interaction was not resolved\",\n        \"Whether HEXIM1 preferentially inhibits CycT1- vs CycT2-containing P-TEFb was not tested\"\n      ]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"In vitro reconstitution demonstrated that 7SK RNA is required to convert HEXIM1 into an active P-TEFb inhibitor, mapping the RNA-recognition and P-TEFb-binding domains of HEXIM1, thereby defining the molecular logic of the inhibitory switch.\",\n      \"evidence\": \"Reconstitution with purified components, gel-shift assays, GST pull-down, point mutagenesis\",\n      \"pmids\": [\"15201869\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether CycT2-specific sequences differentially modulate HEXIM1 affinity was not examined\",\n        \"Signals that trigger 7SK release in vivo remained incompletely defined\"\n      ]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Brd4 was shown to recruit the active (7SK/HEXIM1-free) form of P-TEFb to acetylated chromatin and stimulate CTD phosphorylation, establishing a recruitment mechanism linking histone acetylation to transcription elongation.\",\n      \"evidence\": \"Affinity purification-mass spectrometry, co-immunoprecipitation, ChIP, siRNA knockdown, transcription assays\",\n      \"pmids\": [\"16109376\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether Brd4 preferentially recruits CycT1- vs CycT2-containing P-TEFb was not resolved\",\n        \"The relative contribution of Brd4 vs other recruiters (e.g., MED26, Aire) at different loci was unknown\"\n      ]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Determination of the crystal structure of free Cyclin T2 and the CDK9/CycT1 complex revealed C-type cyclin structural features and a distinctive CDK–cyclin interface rotation, providing a structural framework for understanding P-TEFb assembly and regulation.\",\n      \"evidence\": \"X-ray crystallography, in vitro kinase assays, mutagenesis\",\n      \"pmids\": [\"18566585\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"A co-crystal of CDK9 bound to CycT2 (rather than CycT1) was not obtained\",\n        \"How the structural differences between CycT1 and CycT2 affect substrate selection remained unknown\"\n      ]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Genetic ablation of Ccnt2 in mice demonstrated embryonic lethality and gene-expression profiling after knockdown in ES cells showed CycT1 and CycT2 regulate non-overlapping gene sets, establishing that the two P-TEFb cyclins are functionally non-redundant in vivo.\",\n      \"evidence\": \"Gene trap mutagenesis in mice, beta-galactosidase expression analysis, siRNA knockdown in embryonic stem cells, gene expression profiling\",\n      \"pmids\": [\"19364821\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"The embryonic stage and developmental process at which lethality occurs was not precisely defined\",\n        \"Molecular basis of target gene selectivity between CycT1 and CycT2 was not determined\"\n      ]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"MED26 was identified as a Mediator subunit that acts as a molecular switch exchanging TFIID for SEC/P-TEFb at promoters, revealing a Mediator-dependent pathway for transition from initiation to elongation.\",\n      \"evidence\": \"Affinity purification-mass spectrometry, co-immunoprecipitation, ChIP, transcription assays\",\n      \"pmids\": [\"21729782\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Direct involvement of CycT2-containing P-TEFb in MED26-dependent recruitment was inferred but not specifically demonstrated\",\n        \"Whether MED26 acts genome-wide or at specific promoter classes was not resolved\"\n      ]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"An RNAi screen in thymic epithelial cells identified CCNT2 as a functional collaborator of Aire in driving ectopic autoantigen gene expression, with HNRNPL mediating 7SK/P-TEFb delivery to Aire-containing complexes — extending P-TEFb function to immune tolerance.\",\n      \"evidence\": \"Genome-scale lentiviral shRNA screen, RNA co-immunoprecipitation, lentigenic knockdown mice, flavopiridol treatment\",\n      \"pmids\": [\"24434558\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether CycT2-containing P-TEFb is specifically preferred over CycT1 in Aire-dependent transcription was not tested\",\n        \"The in vivo autoimmune phenotype upon CycT2-specific depletion in thymic epithelium was not assessed\"\n      ]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"CCNT2 was identified as a direct miR-297c-5p target controlling oligodendrocyte precursor differentiation and a miR-192 target promoting cell cycle progression in AML cells, demonstrating cell-type-specific P-TEFb functions regulated at the post-transcriptional level.\",\n      \"evidence\": \"Luciferase reporter assays, siRNA knockdown, lentiviral transduction, flow cytometry, rescue experiments in OPCs and NB4/HL-60 leukemia cells\",\n      \"pmids\": [\"26843650\", \"28409330\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether miRNA-mediated CycT2 regulation shifts the CycT1/CycT2 ratio and alters P-TEFb target selectivity was not explored\",\n        \"In vivo relevance of these miRNA–CCNT2 axes in myelination or leukemogenesis was not established\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"CCNT2 was shown to occupy both the promoter and a distal enhancer of VEGFA and to control alternative splicing by modulating Pol II elongation rate, directly linking P-TEFb elongation kinetics to co-transcriptional splicing decisions.\",\n      \"evidence\": \"ChIP, siRNA silencing, RNA-seq and RT-PCR splice isoform analysis, RNAPII elongation rate measurement\",\n      \"pmids\": [\"34316716\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether CCNT2-dependent splicing regulation extends genome-wide or is locus-specific was not determined\",\n        \"The contribution of enhancer-bound CCNT2 versus promoter-bound CCNT2 to splicing regulation was not separated\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"A major unresolved question is what determines CycT2 versus CycT1 target gene selectivity — whether it reflects differential chromatin recruitment, distinct protein interaction surfaces, or tissue-specific expression ratios.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No genome-wide CycT2 ChIP-seq in comparison with CycT1 has been reported\",\n        \"Structural basis for any CycT2-specific protein interactions remains unknown\",\n        \"Conditional tissue-specific knockouts of CycT2 have not been characterized\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 1, 2, 3]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [7, 11, 13]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005654\", \"supporting_discovery_ids\": [4]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [4, 7]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 1, 5, 8, 13]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [10, 12]},\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [1, 2, 3, 13]}\n    ],\n    \"complexes\": [\n      \"P-TEFb (CDK9/CycT2)\",\n      \"7SK snRNP (inactive P-TEFb/HEXIM1/7SK)\"\n    ],\n    \"partners\": [\n      \"CDK9\",\n      \"HEXIM1\",\n      \"BRD4\",\n      \"MED26\",\n      \"HNRNPL\",\n      \"AIRE\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}